Pharmacokinetic and Clinical Associations Between Doravirine-Containing Antiretroviral Therapy and Injectable and Implantable Hormonal Contraceptive Methods Among Women Living With Human Immunodeficiency Virus in South Africa
We found no detrimental bidirectional drug-drug interactions and few adverse events between doravirine and hormonal contraceptives.
Authors
- Rena C. Patel (ORCID: https://orcid.org/0000-0001-9893-5856)
- Kimberly K. Scarsi (ORCID: https://orcid.org/0000-0001-9406-693X)
- Tommy Williams
- Nompumelelo Sigcu
- Krishnaveni Reddy (ORCID: https://orcid.org/0000-0002-3881-2704)
- David W. Erikson (ORCID: https://orcid.org/0000-0002-3383-9297)
- Nashon Yongo
- Shukri A. Hassan (ORCID: https://orcid.org/0000-0001-6732-9263)
- La-Donna Kapa
- Mohamed Seedat (ORCID: https://orcid.org/0000-0001-9018-3370)
- Thesla Palanee‐Phillips (ORCID: https://orcid.org/0000-0002-0052-5830)
- Merusha Govindasami (ORCID: https://orcid.org/0009-0001-1332-4333)
- Lerato R Shale
- Nkosiphile Ndlovu (ORCID: https://orcid.org/0009-0008-3206-9666)
- Reolebogile Kgoa
- Pooja Maheria
- Lindsay Kew
- Nomasonto Matswake
Institutions
- Oregon National Primate Research Center (US)
- Nebraska Medical Center (US)
- Oregon Health & Science University (US)
- University of the Witwatersrand (ZA)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1093/infdis/jiaf196
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 0.00